Syngene International's Stock Sees -3.0% Decline, But Remains Strong in Long Term

Syngene International, a leading pharmaceutical and drug company, saw a decline of -3.0% in its stock on November 13, 2024. This was in line with the overall performance of the sector, as the company underperformed by -0.63%. The stock touched an intraday low of Rs 869.45, a decrease of -2.5% from the previous day's closing price.

Despite this recent dip, Syngene International's stock is still performing well in the long term. It is currently trading higher than its 20-day, 100-day, and 200-day moving averages. However, it is lower than its 5-day and 50-day moving averages, indicating a short-term decline.

In comparison to the overall market performance, Syngene International's stock has underperformed in the past day and month. While the company's stock saw a decline of -3.00%, the Sensex only saw a decrease of -0.60% in the same time period. Similarly, in the past month, Syngene International's stock saw a decline of -1.93%, while the Sensex saw a decrease of -3.91%.

Overall, Syngene International's stock is currently rated as 'Hold' by MarketsMOJO. With its strong presence in the pharmaceutical and drug industry and consistent performance in the long term, the company remains a key player in the largecap market. Investors should keep an eye on the stock's performance in the short term, while also considering its potential for growth in the long term.